Intended for healthcare professionals

CCBYNC Open access

Anticholinergic drugs and risk of dementia: case-control study

BMJ 2019; 367 doi: (Published 31 October 2019) Cite this as: BMJ 2019;367:l6213

An error occurred in this paper by Richardson and colleagues (BMJ 2018;361:k1315, doi:10.1136/bmj.k1315, published 25 April 2018). The corresponding author’s email address should be The paper and PDF will be updated in due course.

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: